Depressive symptoms and C-reactive protein: The Cardiovascular Risk in Young Finns Study

Psychological Medicine

Volumn 36, Issue 6, 2006, Pages 797-805

  Elovainio, Marko ^a,b   Keltikangas Järvinen, Liisa ^a   Pulkki Råback, Laura ^a   Kivimäki, Mika ^a,c   Puttonen, Sampsa ^a   Viikari, Liisa ^e   Räsänen, Leena ^e   Mansikkaniemi, Kristiina ^d   Viikari, Jorma ^e   Raitakari, Olli T ^e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BECK DEPRESSION INVENTORY; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; FAT INTAKE; FEMALE; GENDER; HUMAN; HYPOTHESIS; INFECTION; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL CONTRACEPTION; PHYSICAL ACTIVITY; POPULATION RESEARCH; PROTEIN ANALYSIS; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DEPRESSION; FEMALE; FINLAND; HUMANS; MALE; OBESITY; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 33646737838     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291706007574     Document Type: Article

References (42)

1. Akerblom, H. K., Uhari, M., Pesonen, E., Dahl, M., Kaprio, E. A., Nuutinen, E. M., Pietikäinen, M., Salo, M. K., Aromaa, A., Kannas, L., Keltikangas-Järvinen, L., Kuusela, V., Räsänen, L., Rönnemaa, T., Knip, M., Telama, R., Välimäki, I., Pyörälä, K. & Viikari, J. (1991). Cardiovascular risk in young Finns. Annals of Medicine 23, 35-39.
2. Anda, R. F., Williamson, D. F., Escobedo, L. G., Mast, E. E., Giovino, G. A. & Remington, P. L. (1990). Depression and the dynamics of smoking. A national perspective. Journal of the American Medical Association 264, 1541-1545.
3. Beck, A. T. & Beck, R. W. (1972). Screening depressed patients in family practice. A rapid technic. Postgraduate Medicine 52, 81-85.
4. Carney, R. M., Freedland, K. E., Miller, G. E. & Jaffe, A. S. (2002). Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. Journal of Psychosomatic Research 53, 897-902.
5. Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R. & Price, L. H. (2004). Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. Journal of Affective Disorders 79, 285-289.
6. Cassano, P. & Fava, M. (2002). Depression and public health: An overview. Journal of Psychosomatic Research 53, 849-857.
7. Coe, C. L., Rosenberg, L. T. & Levine, S. (1988). Prolonged effect of psychological disturbance on macrophage chemiluminescence in the squirrel monkey. Brain Behavior Immunity 2, 151-160.
8. Danner, M., Kasl, S. V., Abramson, J. L. & Vaccarino, V. (2003). Association between depression and elevated C-reactive protein. Psychosomatic Medicine 65, 347-356.
9. Desimoni, J., Bibiloni, A. G., Massolo, C. P. & Renteria, M. (1990). Hyperfine interactions in the cubic semiconductor CdO. Physical Review 41, 1443-1446.
10. Douglas, K. M., Taylor, A. J. & O'Malley, P. G. (2004). Relationship between depression and C-reactive protein in a screening population. Psychosomatic Medicine 66, 679-683.
11. Fent, K. & Zbinden, G. (1987). Toxicity of interferon and interleukin. Trends in Pharmacological Sciences 8, 100-105.
12. Ford, D. E. & Erlinger, T. P. (2004). Depression and C-reactive protein in US adults: Data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 164, 1010-1014.
13. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18, 499-502.
14. Gold, P. W., Wong, M. L., Chrousos, G. P. & Licinio, J. (1996). Stress system abnormalities in melancholic and atypical depression: Molecular, pathophysiological, and therapeutic implications. Molecular Psychiatry 1, 257-264.
15. Greenfield, J. R., Samaras, K., Jenkins, A. B., Kelly, P. J., Spector, T. D., Gallimore, J. R., Pepys, M. B. & Campbell, L. V. (2004). Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109, 3022-3028.
16. Heinrich, P. C., Castell, J. V. & Andus, T. (1990). Interleukin-6 and the acute phase response. Biochemical Journal 265, 621-636.
17. Herbert, T. B. & Cohen, S. (1993a). Depression and immunity: A meta-analytic review. Psychological Bulletin 113, 472-486.
18. Herbert, T. B. & Cohen, S. (1993b). Stress and immunity in humans: A meta-analytic review. Psychosomatic Medicine 55, 364-379.
19. Herva, A., Laitinen, J., Miettunen, J., Veijol, J., Karvonen, J. T., Läksy, K. & Joukamaa, M. (2006). Obesity and depression: Results from longitudinal Northern Finland 1966 Birth Cohort Study. International Journal of Obesity 30, 520-527.
20. Istvan, J., Zavela, K. & Weidner, G. (1992). Body weight and psychological distress in NHANES I. International Journal of Obesity Related Metabolic Disorders 16, 999-1003.
21. Juonala, M., Viikari, J. S., Hutri-Kahonen, N., Pietikainen, M., Jokinen, E., Taittonen, L., Marniemi, J., Ronnemaa, T. & Raitakari, O. T. (2004). The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: Risk factor levels, secular trends and east-west difference. Journal of Internal Medicine 255, 457-468.
22. Katainen, S., Räikkönen, K. & Keltikangas-Järvinen, L. (1999). Adolescent temperament, perceived social support, and depressive tendencies as predictors of depressive tendencies in young adulthood. European Journal of Personality 13, 183-207.
23. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., Wittchen, H. U. & Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8-19.
24. Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F. & Glaser, R. (2002a). Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annual Review of Psychology 53, 83-107.
25. Kiecolt-Glaser, J. K., McGuire, L., Robles, T. F. & Glaser, R. (2002b). Psychoneuroimmunology and psychosomatic medicine: Back to the future. Psychosomatic Medicine 64, 15-28.
26. Ladwig, K. H., Marten-Mittag, B., Lowel, H., Doring, A. & Koenig, W. (2003). Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain, Behavior & Immunity 17, 268-275.
27. Maier, S. F. & Watkins, L. R. (1998). Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review 105, 83-107.
28. Meijer, A., Zakay-Rones, Z. & Morag, A. (1988). Post-influenzal psychiatric disorder in adolescents. Acta Psychiatrica Scandinavica 78, 176-181.
29. Miller, G. E., Cohen, S. & Herbert, T. B. (1999). Pathways linking major depression and immunity in ambulatory female patients. Psychosomatic Medicine 61, 850-860.
30. Miller, G. E., Cohen, S. & Ritchey, A. K. (2002). Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychology 21, 531-541.
31. Nurmi, J. E., Toivonen, S., Salmela-Aro, K. & Eronen, S. (1997). Social strategies and loneliness. Journal of Social Psychology 137, 764-777.
32. Panagiotakos, D. B., Pitsavos, C., Chrysohoou, C., Tsetsekou, E., Papageorgiou, C., Christodoulou, G. & Stefanadis, C. (2004). Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. European Heart Journal 25, 492-499.
33. Pearlin, L. I. (1989). The sociological study of stress. Journal of Health and Social Behavior 30, 241-256.
34. Piche, M. E., Lemieux, S., Weisnagel, S. J., Corneau, L., Nadeau, A. & Bergeron, J. (2005). Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. American Journal of Cardiology 96, 92-97.
35. Plaut, M. (1987). Lymphocyte hormone receptors. Annual Review of Immunology 5, 621-669.
36. Plotsky, P. M., Owens, M. J. & Nemeroff, C. B. (1998). Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatry Clinical North America 21, 293-307.
37. Raitakari, M., Mansikkaniemi, K., Marniemi, J., Viikari, J. & Raitakari, O. T. (2005). Distribution and determinants of serum high-sensitive C-reactive protein in population of young adults. The cardiovascular Risk in Young Finns Study. Journal of Internal Medicine 258, 428-434.
38. Ross, R. (1999). Atherosclerosis is an inflammatory disease. American Heart Journal 138, S419-S420.
39. Sluzewska, A., Rybakowski, J. K., Laciak, M., Mackiewicz, A., Sobieska, M. & Wiktorowicz, K. (1995). Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Annual New York Academy of Science 762, 474-476.
40. Suarez, E. C. (2004). C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosomatic Medicine 66, 684-691.
41. Tilders, F. J., Schmidt, E. D. & de Goeij, D. C. (1993). Phenotypic plasticity of CRF neurons during stress. Annual New York Academy of Science 697, 39-52.
42. Yudkin, J. S., Stehouwer, C. D., Emeis, J. J. & Coppack, S. W. (1999). C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis & Vascular Biology 19, 972-978.